- Docket No.
- 1:26-cv-00431
- District Court
- District of Columbia
Goal
- Block enforcement of an agency action
- Declaration that agency action is unlawful
- Vacate agency action
Issues
Litigation Content
Why This Matters:
Why This Matters:
The Plaintiff argues that the selection of its drug for negotiation under the Inflation Reduction Act’s Medicare drug negotiation program violates the Administrative Procedure Act, the Takings Clause of the Fifth Amendment, the Due Process Clause of the Fifth Amendment, and the Free Speech Clause of the First Amendment. Medicare’s authority to negotiate the price of certain single-source, high-priced drugs is estimated to result in substantial savings for Medicare beneficiaries and the federal government.
Potential Impact:
Potential Impact:
Successful challenges to Medicare’s negotiation authority under the Inflation Reduction Act would reduce savings for Medicare beneficiaries and taxpayers and could severely restrict federal regulatory authority in the health care sector.
News And Analysis (6)
8 Major Filings
- AMICUS BRIEF [PUBLIC CITIZEN ET AL.] (Jun 24, 2026)
- DEFENDANTS’ MOTION TO DISMISS (Jun 23, 2026)
- SCHEDULING ORDER (Jun 15, 2026)
- DECLARATION OF DALIA A. MAHMOUD (May 20, 2026)
- DECLARATION OF MITCHELL F. BRIN (May 20, 2026)
- PLAINTIFF’S MOTION FOR SUMMARY JUDGMENT (Apr 28, 2026)
- SCHEDULING ORDER (Apr 3, 2026)
- COMPLAINT (Feb 11, 2026)